Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Jenner, Peter
Rupniak, Nadia M.J.
Rose, Sarah
Kelly, Eamonn
Kilpatrick, Gavin
Lees, Andrew
and
Marsden, C.David
1984.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
Neuroscience Letters,
Vol. 50,
Issue. 1-3,
p.
85.
Langston, J.William
Irwin, Ian
Langston, Elizabeth B.
and
Forno, Lysia S.
1984.
The importance of the ‘4–5’ double bond for neurotoxicity in primates of the pyridine derivative MPTP.
Neuroscience Letters,
Vol. 50,
Issue. 1-3,
p.
289.
1984.
“On–Off” Phenomenon in Parkinson’s Disease.
New England Journal of Medicine,
Vol. 311,
Issue. 3,
p.
192.
Langston, J. William
Irwin, Ian
Langston, Elizabeth B.
and
Forno, Lysia S.
1984.
Pargyline Prevents MPTP-Induced Parkinsonism in Primates.
Science,
Vol. 225,
Issue. 4669,
p.
1480.
1984.
Parkinson's Disease, 1984.
The Lancet,
Vol. 323,
Issue. 8381,
p.
829.
Williams, A
1984.
MPTP parkinsonism..
BMJ,
Vol. 289,
Issue. 6456,
p.
1401.
Perry, Thomas L.
Yong, Voon Wee
Jones, Karen
Wall, Richard A.
Clavier, Ronald M.
Foulks, James G.
and
Wright, James M.
1985.
Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
Neuroscience Letters,
Vol. 58,
Issue. 3,
p.
321.
William Langston, J.
1985.
MPTP and parkinson's disease.
Trends in Neurosciences,
Vol. 8,
Issue. ,
p.
79.
Sirinathsinghji, D.J.S.
1985.
Behavioural effects in the rat after acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Brain Research,
Vol. 339,
Issue. 2,
p.
366.
Barbeau, A.
Dallaire, L.
Buu, N.T.
Veilleux, F.
Boyer, H.
de Lanney, L.E.
Irwin, I.
Langston, E.B.
and
Langston, J.W.
1985.
New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Life Sciences,
Vol. 36,
Issue. 11,
p.
1125.
Fuller, Ray W.
and
Hemrick-Luecke, Susan K.
1985.
Mechanisms of MPTP (1-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 9,
Issue. 5-6,
p.
687.
Crossman, A.R.
Mitchell, I.J.
and
Sambrook, M.A.
1985.
Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—induced parkinsonism in the macaque monkey.
Neuropharmacology,
Vol. 24,
Issue. 6,
p.
587.
Sirinathsinghji, Dalip J.S.
1985.
Intrahypothalamic infusions of a synthetic heroin substitute, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, potentiate mating behaviour in the female rat.
Brain Research,
Vol. 346,
Issue. 1,
p.
130.
Barbeau, André
Roy, Madeleine
and
Langston, J.William
1985.
NEUROLOGICAL CONSEQUENCE OF INDUSTRIAL EXPOSURE TO 1-METHYL-4-PHENYL-1, 2, 3, 6-TETRAHYDROPYRIDINE.
The Lancet,
Vol. 325,
Issue. 8431,
p.
747.
Calne, D. B.
Langston, J. William
Martin, W. R. Wayne
Stoessl, A. Jon
Ruth, Thomas J.
Adam, Michael J.
Pate, Brian D.
and
Schulzer, Michael
1985.
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.
Nature,
Vol. 317,
Issue. 6034,
p.
246.
Mitchell, I.J.
Cross, A.J.
Sambrook, M.A.
and
Crossman, A.R.
1985.
Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
Neuroscience Letters,
Vol. 61,
Issue. 1-2,
p.
195.
William Langston, J.
1985.
I. MPTP neurotoxicity: An overview and characterization of phases of toxicity.
Life Sciences,
Vol. 36,
Issue. 3,
p.
201.
Burns, R. Stanley
LeWitt, Peter A.
Ebert, Michael H.
Pakkenberg, Henning
and
Kopin, Irwin J.
1985.
The Clinical Syndrome of Striatal Dopamine Deficiency.
New England Journal of Medicine,
Vol. 312,
Issue. 22,
p.
1418.
Doudet, Doris
Gross, Christian
Lebrun-Grandie, Philippe
and
Bioulac, Bernard
1985.
MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study.
Brain Research,
Vol. 335,
Issue. 1,
p.
194.
Lang, A. E.
Birnbaum, A.
Blair, R. D. G.
and
Kierans, C.
1986.
Levodopa dose‐related fluctuations in presumed olivopontocerebellar atrophy.
Movement Disorders,
Vol. 1,
Issue. 2,
p.
93.